There is decreased risk for CV events and mortality in patients with cardiac autonomic neuropathy that receive intensive glycemic treatment.

Diabetic autonomic neuropathy (DAN) is common complication of diabetes mellitus (DM), associated with development of angiopathies and increased mortality. The objective of the study was to determine ...